Articles

Why Financial Credibility Impacts Who Gets Funded in Cannabis

Key Takeaways: 

  • Access to capital in the cannabis industry is increasingly driven by financial credibility, not just market opportunity or growth potential.
  • Outdated accounting, inventory, and reporting systems not only create operational friction by generating bad data and misleading KPIs, they are a barrier to accessing capital.
  • Accurate, organized, and well-documented financial records are essential to show investors compliance with tax regulations, including IRC Section 280E for adult-use operations; for medical-only companies, they also demonstrate tax efficiency, including the ability to leverage newly available federal tax credits such as the R&D tax credit.

As federal cannabis policy moves through a period of significant change, operators are facing an evolving capital environment. The April reclassification of medical cannabis to Schedule III has expanded the population of potential investors and lenders for such companies. At the same time, the uncertainty around the outcome of the DEA’s administrative hearing on potential adult-use rescheduling means companies with adult-use operations continue to navigate more limited sources of capital. What both have in common is that today’s investors and lenders are expecting management to deliver accurate and timely financial data to support projections or validate results.

To meet investor and creditor expectations, you need accurate, organized, and supportable financial data — along with policies and processes that support its creation and retention.

Chart describing the components of financial credibility.

Credibility Is a Gatekeeper to Capital

Investors and lenders are not just evaluating your financial projections and metrics; they are evaluating your credibility. Missing reporting deadlines, changing cash forecasts, or inaccurate key performance indicators (KPIs) and metrics at a minimum will delay or increase the cost of any capital raise. At worst, you can lose out on a capital raise altogether.

When financial data is delayed, incomplete, or difficult to reconcile, it raises questions about the underlying processes and controls supporting the business. In turn, that raises questions about an organization’s ability to put capital to work efficiently, or to support the growth resulting from an increased capital base.

Outdated Systems Create More Than Inefficiency

We find that many cannabis operators still rely on systems built during early-stage growth. Spreadsheets, disconnected point-of-sale tools, standalone inventory systems, and legacy accounting platforms often coexist without full integration.

Individually, these tools may function. Together, they often create friction. These disconnects compound quickly, particularly as operators look to leverage a capital infusion to scale across multiple entities, locations, or license types.

Common symptoms of such friction include:

  • Delayed month-end closes
  • Repeated reconciliation adjustments
  • Unclear cash positioning
  • Inconsistent expense categorization
  • Inventory variances between systems
  • Manual reporting across entities or locations

Many operators recognize these symptoms but underestimate their impact. They typically signal underlying system, process, and control gaps, which create significant operational and financial data risk. These issues are often framed as accounting challenges. In practice, they are operational constraints.

When leadership cannot rely on financial data in real time, or even get timely and consistent information, decision-making slows. Pricing strategy, expansion planning, staffing decisions, and capital allocation all become harder to execute with confidence. Over time, that lag becomes a competitive disadvantage.

Clean Data Is Foundational to Cannabis Tax Compliance

Tax compliance is one of the clearest places where financial credibility gets tested — and where gaps get noticed by the people deciding whether to invest or lend.

Nowhere is financial clarity more consequential than in tax reporting. Cannabis businesses operate under a patchwork of federal and state tax regulations. When financial data is inconsistent or incomplete, several tax compliance risks emerge:

  • Misclassification of deductible versus non-deductible expenses
  • Inaccurate or unsupported cost of goods sold (COGS) calculations
  • Overstatement or understatement of taxable income
  • Increased exposure during IRS review or audit
  • Difficulty aligning book income with tax reporting requirements
  • Failing to leverage available tax credits

For many operators, these are not theoretical risks. They surface in due diligence, they erode investor confidence, and they translate into real cash impact.

The Competitive Reality: Clean Data Is No Longer Optional

The cannabis industry is entering a more disciplined phase of growth. Capital is more selective, regulatory oversight is expanding, and expectations around financial transparency are rising. In this environment, clean data is a competitive requirement. Today, financial discipline has become both a differentiator and a safeguard. Businesses that invest in financial clarity gain more than better reporting. They gain credibility with capital providers, resilience in tax reporting, stronger internal controls, and more informed decision-making.

How MGO Can Help

We work with cannabis operators across cultivation, manufacturing, distribution, and retail to strengthen financial reporting, improve compliance readiness, and support scalable growth.

Whether you want to augment your internal team or transform your accounting function, our client accounting solutions bring structure and consistency to your financial operations. If your financial reporting is slowing decision-making, limiting visibility, creating friction in capital or banking conversations, now is the time to reassess your approach.

Contact our team today to strengthen your accounting foundation and build the financial clarity needed to support scalable growth and capital readiness.